PROGRAM OBJECTIVESAfter participating in the Launch Excellence MasterClass program, participants should be better able to:Understand the expanding Medical Affairs leadership role in Launch Excellence and how Medical Affairs expertise should be leveraged throughout the process to maximize valueIdentify core components of a successful launch from a company and learn from external stakeholders' preferencesDemonstrate cross-functional collaboration and alignment on shared goals and expectations when working across internal and external stakeholder networksSupporting the optimization of tools, systems and processes to elevate organizational launch capabilities and readiness with clear roles and responsibilities for strategic and implementation objectivesAddress current real-world launch challenges driven by an accelerated shift to digital and remote working through case studies and live discussion
関連コンテンツ
November 5, 2026
Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk
Sponsor:
ICON

November 5, 2026
Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence
Sponsor:
Veradigm
November 5, 2026
Network meta-analysis and its role in evidence-based decision-making
Sponsor:
ICON
November 5, 2026
Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases
Sponsor:
ICON

November 5, 2026
Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access
Sponsor:
PRECISIONheor
OPEN Health
PRMA Consulting

November 5, 2026
Cell & Gene Therapies - Beginning with the End in Mind
Sponsor:
Magnolia Market Access

November 5, 2026
Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data

November 5, 2026
Expediting drug product development and commercialization in global markets with global filing strategies

November 5, 2026
Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

November 5, 2026
The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval

November 5, 2026
US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th

November 5, 2026
Become an expert & hone your skills for Pharma, Biotech, Medical & Diagnostic Device launches

November 5, 2026
Stay Ahead of the Game: Learn How to Conduct an Evidence-Based GVD Faster and Smarter to Improve Market Access
Sponsor:
DistillerSR

November 5, 2026
Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations
Sponsor:
Self Care Catalysts, an Alira Health Company

November 5, 2026
Value-Based Agreements - Are We Going to See More or Less of Them?
Sponsor:
Actu-Real

November 5, 2026
Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access
Sponsor:
OPEN Health
PRECISIONheor
PRMA Consulting
関連コンテンツ
デモを見る
現代のライフサイエンスを支えるデジタル基盤
プロバイダー、ワークフロー、承認、コンプライアンス、データ、支出を一元管理できるインテリジェントなプラットフォームをご紹介します。複雑なプロジェクトをより迅速に、高い可視性と管理体制のもとで推進することが可能です。










